$ELOX Eloxx Pharmaceuticals, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Eloxx Pharmaceuticals, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Eloxx Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Eloxx Pharmaceuticals, Inc. for free.

CIK Number: 0001035354
IRS Number: 841368850
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Trading Symbol: ELOX
Company Address: 950 WINTER STREET WALTHAM 02451
Phone number: 858-909-0749
Former name: NAVA LEISURE USA INC, date of change: 1997-03-10
Former name: SENESCO TECHNOLOGIES INC, date of change: 1999-10-06
Former name: Sevion Therapeutics, Inc., date of change: 2014-09-30

Market Capitalization: $4.75M
Prev close: $0.23
Average Daily Volume: 35,194
Days Low: $0.00
Year Low: $0.08
Year High: $0.39

Eloxx Pharmaceuticals, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Ward RobertCHIEF EXECUTIVE OFFICER228,59552,577shares bought: 228,595 / shares sold: -133,038 STRONG BUYDec 28 201824 days ago

View all Eloxx Pharmaceuticals, Inc. insiders.

Eloxx Pharmaceuticals, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 28 2018ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...Option ExerciseM0.00213,5950427,190
Dec 28 2018ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...GiftG0.0050,000095,557145.6 K to 95.6 K (-34.35 %)
Dec 28 2018ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...Payment of ExerciseF12.6083,0381,046,279145,557228.6 K to 145.6 K (-36.33 %)
Dec 28 2018ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...BuyM0.00213,5950228,59515 K to 228.6 K (+1,423.97 %)
Jun 29 2018ELOXEloxx Pharmaceutic ...Noiman SilviaChief Executive Off ...Option ExerciseM0.00349,4002100
Jun 29 2018ELOXEloxx Pharmaceutic ...Noiman SilviaChief Executive Off ...BuyM0.00349,400210490,789141.4 K to 490.8 K (+247.12 %)
Jun 26 2018ELOXEloxx Pharmaceutic ...Williams Gregory C.Chief Operating Off ...Option ExerciseA18.84300,0005,652,000300,000
Jun 26 2018ELOXEloxx Pharmaceutic ...Snow David P.Chief Business Offi ...Option ExerciseA18.85200,0003,770,000200,000
Jun 26 2018ELOXEloxx Pharmaceutic ...Williams Gregory C.Chief Operating Off ...Option ExerciseA18.84300,0005,652,000300,000
Jun 26 2018ELOXEloxx Pharmaceutic ...Snow David P.Chief Business Offi ...Option ExerciseA18.85200,0003,770,000200,000
Jun 20 2018ELOXEloxx Pharmaceutic ...Belloff Neil S.General Counsel and ...Option ExerciseA20.85125,0002,606,250125,000
Jun 19 2018ELOXEloxx Pharmaceutic ...Veinrib GadiDirectorOption ExerciseA23.2740,000930,80040,000
Jun 19 2018ELOXEloxx Pharmaceutic ...Seehra JasbirDirectorOption ExerciseA23.2740,000930,80040,000
Jun 19 2018ELOXEloxx Pharmaceutic ...Rubin Steven DDirectorOption ExerciseA23.2740,000930,80040,000
Jun 19 2018ELOXEloxx Pharmaceutic ...Pontifax Management III G.P. ( ...10% OwnerOption ExerciseA23.2740,000930,80040,000

View all Eloxx Pharmaceuticals, Inc. insider transactions.